HAYWARD, Calif., Nov. 20 /PRNewswire/ -- Guava Technologies, Inc., a leading developer of cost-effective and accessible cell-analysis systems for life science research, drug discovery, development and clinical diagnostics, announced today that Lawrence F. Bruder, the company's president and chief executive officer, will present at the 18th Annual Piper Jaffray Health Care Conference on Wednesday, November 29 at 2:30 p.m. EST at the Pierre Hotel in New York City.
About Guava Technologies
Guava Technologies, Inc., a privately held biotechnology and medical device company, is the leading provider of on-demand, easy-to-use single cell analysis systems. Guava Personal Cell Analysis (PCA(TM)) systems, including the Guava PCA, Guava PCA-96, Guava EasyCyte and Guava EasyCyte Mini systems, are integrated, fully optimized, microcapillary cytometry systems with embedded absolute cell counting capability. Used worldwide by the life sciences, biotechnology, and pharmaceutical industries, as well as clinical testing institutions (outside the United States and Europe), Guava's products have broad applications in scientific research and throughout the drug discovery and lead optimization process, as well as for cell counting and optimization of commercial bio-pharmaceutical production. Guava offers a variety of reagents and dedicated software modules for the Guava PCA systems, enhancing the system's overall ease-of-use.
More information about the company and its products is available at http://www.guavatechnologies.com.
Guava and Guava Technologies, Inc. are registered trademarks of Guava Technologies, Inc. EasyCyte and PCA are trademarks of Guava Technologies, Inc.
Guava Technologies, Inc.
CONTACT: Media: Justin Jackson, +1-212-213-0006, firstname.lastname@example.org, orInvestors: John Cummings, +1-415-352-6262, email@example.com, both ofBurns McClellan for Guava Technologies, Inc.